# Recipharm Strangnas AB – FDA Inspection, Sep 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/recipharm-strangnas-ab/42f03dca-5d05-46ef-9382-3f2475c2af8d
Source feed: FDA_Inspections

> FDA inspection 1101934 of Recipharm Strangnas AB, September 06, 2019. Classification: Voluntary Action Indicated (VAI). 10 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101934
- Company Name: Recipharm Strangnas AB
- Inspection Date: 2019-09-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 10

## Related Documents

- FDA Inspection 1265346 - 2022-11-18
- FDA Inspection 1173099 - 2019-05-16

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jiao-yang/82c32489-41bf-4dfa-b0bd-0414418d4b13)
- [FDA Associated Person](https://www.keypedia.com/people/tenzin-jangchup/733eb315-0eeb-40ce-af6d-03b406a9235d)

Company: https://www.keypedia.com/companies/recipharm-strangnas-ab/ee3a0733-8b2e-40e5-b611-fc4098625398

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8